CIPLA Gearing Up for Growth Indian pharma companies have to adopt a well-developed R and D base if they are to compete in the increasingly WTOdominated world. CIPLA is keen that government policy towards the intellectual property regime must safeguard the interest of the indigenous industry. Y K Hameid, CMD, says,